NRC (NRC Health Common Stock) Stock Analysis - News
NRC Health Common Stock (NRC) is a publicly traded Healthcare sector company. As of May 21, 2026, NRC trades at $19.50 with a market cap of $422.34M and a P/E ratio of 0.38. NRC moved +2.77% today. Year to date, NRC is +2.45%; over the trailing twelve months it is +39.57%. Its 52-week range spans $9.76 to $22.99. Rallies surfaces NRC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in NRC news today?
National Research Shares Plunge 27% After Q4 EPS Drops 45% and Revenues Dip 5%: National Research Corporation posted Q4 adjusted EPS of $0.16, down from $0.29 a year earlier, while quarterly revenues declined 5% to $35.2 million. The company’s stock slid 27% following the report as GAAP net income fell to $1.8 million and client attrition pressured growth.
HARRISON SHANE R bought 8.00K (~$98.16K) on Feb 17, 2026.
Freeman Jordan Nicole bought 771 (~$10.00K) on Jul 31, 2025.
BEANS PATRICK E bought 2.50K (~$33.97K) on May 12, 2025.
NRC Analyst Consensus
NRC analyst coverage data. Average price target: $0.00.
Common questions about NRC
What changed in NRC news today?
National Research Shares Plunge 27% After Q4 EPS Drops 45% and Revenues Dip 5%: National Research Corporation posted Q4 adjusted EPS of $0.16, down from $0.29 a year earlier, while quarterly revenues declined 5% to $35.2 million. The company’s stock slid 27% following the report as GAAP net income fell to $1.8 million and client attrition pressured growth.
Does Rallies summarize NRC news?
Yes. Rallies summarizes NRC news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is NRC research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NRC. It does not provide personalized investment advice.
